Stay updated on IBAT Inhibitor A4250 for Cholestatic Pruritus Clinical Trial

Sign up to get notified when there's something new on the IBAT Inhibitor A4250 for Cholestatic Pruritus Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IBAT Inhibitor A4250 for Cholestatic Pruritus Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    2%
    Check dated 2025-05-29T05:56:04.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-04-30T13:54:27.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The webpage has undergone significant changes, including the removal of detailed study information regarding A4250 for Primary Biliary Cirrhosis, while retaining some key identifiers such as the study's location and collaborators.
    Difference
    34%
    Check dated 2025-04-16T01:47:23.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-08T20:28:47.000Z thumbnail image
  7. Check
    97 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    2%
    Check dated 2025-02-24T18:28:38.000Z thumbnail image
  8. Check
    111 days ago
    Change Detected
    Summary
    The page now includes a notice about heavy traffic affecting NLM-NCBI services and mentions Sahlgrenska University Hospital, while the reference to Vastra Gotaland Region has been removed.
    Difference
    3%
    Check dated 2025-02-10T09:19:21.000Z thumbnail image

Stay in the know with updates to IBAT Inhibitor A4250 for Cholestatic Pruritus Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IBAT Inhibitor A4250 for Cholestatic Pruritus Clinical Trial page.